Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
224 | 3 | COLONOSCOPY//COLORECTAL CANCER//MICROSATELLITE INSTABILITY | 49334 |
511 | 2 | MICROSATELLITE INSTABILITY//LYNCH SYNDROME//COLORECTAL CANCER | 15669 |
1982 | 1 | PANITUMUMAB//CETUXIMAB//KRAS | 2440 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PANITUMUMAB | authKW | 2011717 | 10% | 63% | 249 |
2 | CETUXIMAB | authKW | 1611955 | 19% | 27% | 461 |
3 | KRAS | authKW | 1214509 | 16% | 25% | 382 |
4 | METASTATIC COLORECTAL CANCER | authKW | 619769 | 8% | 25% | 195 |
5 | KRAS MUTATION | authKW | 381634 | 5% | 25% | 119 |
6 | COLORECTAL CANCER | authKW | 372317 | 33% | 4% | 801 |
7 | BRAF | authKW | 314866 | 8% | 12% | 196 |
8 | ANTI EGFR THERAPY | authKW | 185732 | 1% | 55% | 26 |
9 | DIGEST ONCOL UNIT | address | 168627 | 2% | 25% | 52 |
10 | MCRC | authKW | 165289 | 1% | 53% | 24 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 40132 | 66% | 0% | 1604 |
2 | Pathology | 2462 | 9% | 0% | 229 |
3 | Medical Laboratory Technology | 759 | 3% | 0% | 77 |
4 | Gastroenterology & Hepatology | 553 | 5% | 0% | 127 |
5 | Medicine, Research & Experimental | 255 | 5% | 0% | 123 |
6 | Pharmacology & Pharmacy | 229 | 8% | 0% | 202 |
7 | Cell Biology | 38 | 4% | 0% | 104 |
8 | Biotechnology & Applied Microbiology | 37 | 3% | 0% | 79 |
9 | Genetics & Heredity | 35 | 3% | 0% | 76 |
10 | Surgery | 25 | 4% | 0% | 102 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DIGEST ONCOL UNIT | 168627 | 2% | 25% | 52 |
2 | FALCK MED ONCOL | 122673 | 1% | 50% | 19 |
3 | NIGUARDA CANC | 110540 | 1% | 34% | 25 |
4 | CELL BIOL BIOTHER Y UNIT | 98984 | 1% | 33% | 23 |
5 | MOL DIGEST ONCOL | 86093 | 0% | 67% | 10 |
6 | UNIT MED ONCOL 1 | 74716 | 0% | 64% | 9 |
7 | DNA REPAIR GENOME STABIL RADIAT ONCOL | 66418 | 0% | 86% | 6 |
8 | MED ONCOL | 62990 | 20% | 1% | 493 |
9 | EXPT CLIN MED SURG F MAGRASSI A LANZAR | 57525 | 0% | 64% | 7 |
10 | RADIAT ONCOL MED PHYS BIOPHYS | 51660 | 0% | 100% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLINICAL COLORECTAL CANCER | 133311 | 3% | 14% | 74 |
2 | TARGETED ONCOLOGY | 16486 | 1% | 5% | 24 |
3 | ANNALS OF ONCOLOGY | 10402 | 3% | 1% | 83 |
4 | JOURNAL OF MOLECULAR DIAGNOSTICS | 8555 | 1% | 2% | 28 |
5 | CLINICAL CANCER RESEARCH | 6720 | 4% | 1% | 90 |
6 | BRITISH JOURNAL OF CANCER | 5134 | 4% | 0% | 86 |
7 | BMC CANCER | 4435 | 2% | 1% | 52 |
8 | JOURNAL OF CLINICAL ONCOLOGY | 4307 | 3% | 0% | 75 |
9 | ONCOLOGIST | 3709 | 1% | 1% | 26 |
10 | FUTURE ONCOLOGY | 3579 | 1% | 1% | 21 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PANITUMUMAB | 2011717 | 10% | 63% | 249 | Search PANITUMUMAB | Search PANITUMUMAB |
2 | CETUXIMAB | 1611955 | 19% | 27% | 461 | Search CETUXIMAB | Search CETUXIMAB |
3 | KRAS | 1214509 | 16% | 25% | 382 | Search KRAS | Search KRAS |
4 | METASTATIC COLORECTAL CANCER | 619769 | 8% | 25% | 195 | Search METASTATIC+COLORECTAL+CANCER | Search METASTATIC+COLORECTAL+CANCER |
5 | KRAS MUTATION | 381634 | 5% | 25% | 119 | Search KRAS+MUTATION | Search KRAS+MUTATION |
6 | COLORECTAL CANCER | 372317 | 33% | 4% | 801 | Search COLORECTAL+CANCER | Search COLORECTAL+CANCER |
7 | BRAF | 314866 | 8% | 12% | 196 | Search BRAF | Search BRAF |
8 | ANTI EGFR THERAPY | 185732 | 1% | 55% | 26 | Search ANTI+EGFR+THERAPY | Search ANTI+EGFR+THERAPY |
9 | MCRC | 165289 | 1% | 53% | 24 | Search MCRC | Search MCRC |
10 | ANTI EGFR MONOCLONAL ANTIBODIES | 149431 | 1% | 64% | 18 | Search ANTI+EGFR+MONOCLONAL+ANTIBODIES | Search ANTI+EGFR+MONOCLONAL+ANTIBODIES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |